BANK VONTOBEL/CALL/CVS HEALTH/56/0.1/20.12.24 Share Price

Warrant

DE000VD5J4R6

Market Closed - Boerse Frankfurt Warrants 11:23:39 02/07/2024 pm IST
0.56 EUR -6.67% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/56/0.1/20.12.24
Current month-12.50%
1 month-11.11%
Date Price Change
02/24/02 0.56 -6.67%
01/24/01 0.6 -6.25%
28/24/28 0.64 +12.28%
27/24/27 0.57 -22.97%
26/24/26 0.74 -2.63%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 11:23 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD5J4R
ISINDE000VD5J4R6
Date issued 03/05/2024
Strike 56 $
Maturity 20/12/2024 (171 Days)
Parity 10 : 1
Emission price 0.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.35
Spread 0.01
Spread %1.79%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.52 USD
Average target price
69.1 USD
Spread / Average Target
+20.12%
Consensus